[Assessment of the use by hospital pharmacists of the opinions issued by the Haute Autorité de santé and the economic analysis tools proposed to them].

Évaluation de l’utilisation par les pharmaciens hospitaliers des avis émis par la Haute Autorité de santé et des outils économiques qui leur sont proposés.
Analyse d’impact budgétaire Avis d’efficience Budget impact model Cost-effectiveness analysis Cost-effectiveness report Health product Hospital Hospital pharmacist Hôpital Pharmaciens hospitaliers Produits de santé Referencing Référencement Évaluation médico-économique

Journal

Annales pharmaceutiques francaises
ISSN: 0003-4509
Titre abrégé: Ann Pharm Fr
Pays: France
ID NLM: 2985176R

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 26 08 2018
revised: 29 10 2018
accepted: 30 10 2018
pubmed: 27 1 2019
medline: 8 6 2019
entrez: 27 1 2019
Statut: ppublish

Résumé

In French hospitals, the supply and management of drugs are missions of pharmacists. The aim of this study is to assess the use of efficacy and economics opinions of the Haute Autorite de santé (HAS) in hospital referencing of drugs in France in 2017. A questionnaire for hospital pharmacists was developed to establish their knowledge and their uses of Transparency Commission and Economic and Public Health Evaluation Committee opinions. This survey was distributed by the ADIPH association in July 2017. This questionnaire included 35 questions. Despite the health professional are more and more interesting by economics analysis, only 30 % of hospitals pharmacists of this panel declared to use HAS economic opinions (versus 80% for Transparency Commission opinions). Among these pharmacists, 86% used this report in the hospital referencing of drugs. Through this analysis, some prospects for improvement can be seen in the health professional formation, cost-effectiveness report publication and the use of cost-effectiveness analysis. This study is an overview of the use of opinions provided by the HAS. This thesis established a basis to reflection on the use of economics reports and models in the hospital decisions.

Sections du résumé

BACKGROUND BACKGROUND
In French hospitals, the supply and management of drugs are missions of pharmacists. The aim of this study is to assess the use of efficacy and economics opinions of the Haute Autorite de santé (HAS) in hospital referencing of drugs in France in 2017.
METHODS METHODS
A questionnaire for hospital pharmacists was developed to establish their knowledge and their uses of Transparency Commission and Economic and Public Health Evaluation Committee opinions. This survey was distributed by the ADIPH association in July 2017. This questionnaire included 35 questions.
RESULTS RESULTS
Despite the health professional are more and more interesting by economics analysis, only 30 % of hospitals pharmacists of this panel declared to use HAS economic opinions (versus 80% for Transparency Commission opinions). Among these pharmacists, 86% used this report in the hospital referencing of drugs.
CONCLUSION CONCLUSIONS
Through this analysis, some prospects for improvement can be seen in the health professional formation, cost-effectiveness report publication and the use of cost-effectiveness analysis. This study is an overview of the use of opinions provided by the HAS. This thesis established a basis to reflection on the use of economics reports and models in the hospital decisions.

Identifiants

pubmed: 30683487
pii: S0003-4509(18)30149-4
doi: 10.1016/j.pharma.2018.10.004
pii:
doi:

Types de publication

Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

159-167

Informations de copyright

Copyright © 2018 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

H Moutier (H)

Université de Caen, 14000 Caen, France. Electronic address: helene.moutier@hotmail.com.

F Bocquet (F)

Inserm UMR S 1145, faculté de pharmacie de Paris, institut droit et santé, université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France; Service évaluations pharmaceutiques et bon usage, agence générale des équipements et des produits de santé, Assistance publique-Hôpitaux de Paris, 75005 Paris, France.

S Bourguignon (S)

Société IQVIA, 92099 La Défense cedex, France.

P Paubel (P)

Inserm UMR S 1145, faculté de pharmacie de Paris, institut droit et santé, université Paris Descartes, Sorbonne Paris Cité, 75005 Paris, France; Service évaluations pharmaceutiques et bon usage, agence générale des équipements et des produits de santé, Assistance publique-Hôpitaux de Paris, 75005 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH